BioAtla, Inc. ·

BCAB 8-K 2026-09-29

BioAtla, Inc. (BCAB) 8-K dated 2026-09-29 — accession 0001193125-26-407817. This URL is the filing, not the BCAB hub.

BioAtla, Inc. (BCAB) is a biotechnology company listed on NASDAQ.

BioAtla, Inc. filed a 8-K on 2026-09-29. Accession 0001193125-26-407817.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.

Not investment advice. The BCAB SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR

Lician Pro $19.99/mo or $149/yr